KAEL-GemVax Of S. Korea Reports Pancreatic Cancer Vaccine Works
This article was originally published in PharmAsia News
Executive Summary
South Korea's KAEL-GemVax, a biopharmaceutical company, said it was nearing development of the first vaccine for preventing pancreatic cancer